As we mark World Alzheimer's Month, attention is once again focused on the millions of people across Europe affected by Alzheimer's disease and other dementias. Alzheimer’s disease (AD) is at a turning point in Europe, with breakthroughs in therapies and diagnostics having the potential to transform approaches to care and management of the disease. Despite growing recognition of the need for comprehensive policy action to tackle AD, current efforts across Europe remain insufficient.
